“P079 | THE ROLE OF GUT MICROBIOTA IN MIGRAINE SUBJECTS TREATED WITH ANTI-CGRP MONOCLONAL ANTIBODIES: RESULTS THE SPHERA PROJECT: F. Muscariello1|2, G. Vaghi1|2, R. Greco2, V. Grillo1|2, M. Corrado2, F. Cammarota1|2, B. Agostini1|2, M. Giraudo1|2, C. Angeli1|2, M. Allena2, E. Guaschino2, N. Ghiotto2, R. Ornello3, S. Sacco3, C. Demartini2, M. Francavilla1|2, S. Facchetti1|2, V. Pazienza4, D. Sproviero2, G. Sances2, C. Tassorelli1|2, R. De Icco1|2 | 1Department of Brain and Behavioral Sciences, University of Pavia, Italy; 2Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy; 3Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; 4Division of Gastroenterology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy”. 2026. Confinia Cephalalgica 36 (s1). https://doi.org/10.4081/cc.2026.16035.